ckd semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular (CV) causes in patients with type 2 diabetes (T2D) and ca. 2024 #ERA24 🇸🇪 #Nephpearls https://www.nejm.org/doi/full/10.1056/NEJMoa2403347 Ozempic Slows Kidney Disease, Now

The remnants of these fat cells are then gradually eliminated through the lymphatic system

Just under three years ago, the Food and Drug Administration deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking commonly available products

This is the single most effective intervention for men with clinically low T, period

Heinemeier KM, Mackey AL, Doessing S, Hansen M, Bayer ML, Nielsen RH, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] Sohmiya M, Tanaka M, Tak NW, Yanagisawa M, Tanino Y, Suzuki Y, Okamoto K, Yamamoto Y

How do we decide from a clinical perspective where we start with each patient